Primary dysmenorrhea. Other specified female pelvic inflammatory diseases
Conditions
Interventions
Intervention 1: Intervention group: Intervention group: The drug used for the intervention group is hofaricon oil. This drug was manufactured by Danesh Banyan Zardband company with high quality and wa
Sponsors
Ahvaz University of Medical Sciences
Eligibility
Sex/Gender
Female
Age
17 Years to 30 Years
Inclusion criteria
Inclusion criteria: Suffering from grade 2 and 3 primary dysmenorrhea according to verbal multidimensional criteria Female students aged 17-30 years Absence of medical illness (diabetes, blood pressure, epilepsy, any kind of heart disease, rheumatism, and neurological diseases...) Has grade 2 and 3 primary dysmenorrhea based on multidimensional speech criteria Full consent to participate in the studyf Regular menstrual cycles with intervals of 21 to 35 days6- Menstrual bleeding without clots (light and moderate bleeding) Menstrual bleeding without clots (light and moderate bleeding) The onset and duration of primary dysmenorrhea from a few hours before menstruation to the second day of bleeding - Not using anticoagulants, narcotics, benzodiazepines Not using contraceptive pills, painkillers and other herbal medicines as well as relaxation methods or acupressure to relieve primary dysmenorrhea. History of allergy to herbal medicines Absence of stressful factors in the last two months, special dietary needs - No history of pelvic inflammatory disease, myoma and pelvic tumors
Exclusion criteria
Exclusion criteria: Continuous use of nutritional supplements and vitamins
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Intensity of pain. Timepoint: Subjects will fill the questionnaires half an hour after oil massage during the second day of menstruation in both consecutive cycles. Method of measurement: McGill pain questionnaire. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public Contactleila bozorgian
Ahvaz University of Medical Sciences
Outcome results
None listed